Mass Layoffs Continue Across The Biotech Sector. What Does This Mean For Pharma’s Future?

More than 115 biotech companies have announced layoffs this year, on track to easily surpass 2022’s numbers. While this is not a new trend, the current trajectory is concerning, as it portends more difficult times ahead for the pharmaceutical industry–already in the midst of a major upheaval. It should also be another wake-up call to pharma executives: the old way of doing business needs to change–and urgently.